(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Osteoarthritis (OA)
This six-month, 10-visit study will evaluate the safety and effectiveness of an investigational agent in adults with daily moderate-to-severe knee pain due to OA. Enrollment has begun at more than 35 sites in the United States. Please visit http://arthritisoftheknee.com for more information.
Research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat109.html.
-----
Lung Cancer or Non-Small Cell Lung Cancer
This study will compare survival rates among women using CT-2103 to survival rates of women using paclitaxel. Females 18 or older with adequate bone marrow, renal and hepatic function may be eligible Patients may not participate if they have had prior systemic chemotherapy for the treatment of lung cancer, or grade 2 or greater neuropathy. Other criteria apply.
Research sites are located worldwide.
More information
Please see http://www.centerwatch.com/patient/studies/cat34.html
or
http://www.centerwatch.com/patient/studies/cat683.html.
-----
Diabetic Neuropathy
This study will evaluate if people with lower extremity peripheral nerve disease or diabetic neuropathy have limitations in strength, sensation, and balance that place them at risk for falling. Volunteers 30-85 who have a diagnosis of lower extremity peripheral nerve disease or diabetes with frequent foot numbness, tingling, and/or pain may be eligible.
The research site is in Lexington, Ky.
More information
Please see http://www.centerwatch.com/patient/studies/cat253.html.
-----
Copyright 2006 Thomson CenterWatch. All rights reserved.
